S&P Pharmaceuticals SPDR (XPH)
$53.69
0.30 (0.56%)
19:59 EST
XPH Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
3.03M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
23,500
Day's Range
53.23 - 53.99
52-Week Range
30.30 - 54.60
Dividend & Yield
0.24 (0.45%)
XPH Stock Predictions, Articles, and S&P Pharmaceuticals SPDR News
- From InvestorPlace
- From the Web
7 Pharmaceutical Stocks to Buy for 2021 and Beyond
Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.
Apellis is Outperforming the Pharmaceutical Sector
By
Ken Trester
This week I want to take a bullish position in the underperforming pharmaceutical sector with Apellis Pharmaceuticals, Inc. (NASDAQ:APLS).
Use Johnson & Johnson for Quick Income
By
Ken Trester
Traders need to be selective with their options, and Johnson & Johnson (NYSE:JNJ) has proven itself resilient.
Collect on the Pharmaceutical Boom With Eli Lilly
By
Ken Trester
Eli Lilly and Company (NYSE:LLY) provided optimistic guidance for 2020 today, and it looks like the stock will head higher at the open this morning.
3 Healthcare ETFs to Sell Amid Political Headwinds
While the rest of the market continues upward, the healthcare sector -- and healthcare ETFs -- continue to struggle.
5 Best-Performing Sector ETFs of July
We have highlighted sector ETFs that witnessed handsome gains last month and could be better plays in the months ahead should the trends prevail. Compare Broker....
7 Best Healthcare ETFs for the Rest of 2018
Some of the best healthcare ETFs to buy are more "traditional", while others focus on very specific areas of the industry. These seven healthcare ETFs should deliver for investors over the remainder of 2018.
What Lies in Store for Pharma ETFs?
Pharma stocks have done well this year; what lies ahead?
When You Exit the Market, Don’t Let The Door Hit You On Your Way Out
You cannot make this stuff up. The median stock in the S&P 500 has never been more overvalued on these key metrics. Now's the time for caution...
3 “Happy New Year” ETFs to Buy for Huge Growth
Unwarranted bearishness and strong technicals make these three ETFs good bets for the New Year.